0.191
-0.036 (-15.86%)
-0.036 (-15.86%)
Upgrade to Real-Time
Market Closed
| Volume | 449,626 |
|
|||||
| News | - | ||||||
| Day High | 0.228 | Low High |
|||||
| Day Low | 0.17 | ||||||
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Oncotelic Therapeutics Inc (QB) | OTLC | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.036 | -15.86% | 0.191 | 16:01:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.227 | 0.17 | 0.228 | 0.227 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 84 | 449,626 | $ 0.19013 | $ 85,487 | - | 0.0805 - 0.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:58:01 | 1,000 | $ 0.191 | USD |
Period:
Draw Mode:
Oncotelic Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 72.12M | 377.61M | 170.97M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 8.61k | $ - | - | - | - |
Oncotelic Therapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.23 | 0.23 | 0.1503 | 0.2080599 | 123,080 | -0.039 | -16.96% |
| 1 Month | 0.2295 | 0.235 | 0.1503 | 0.2204105 | 108,792 | -0.0385 | -16.78% |
| 3 Months | 0.235 | 0.259 | 0.1503 | 0.23111 | 114,445 | -0.044 | -18.72% |
| 6 Months | 0.118 | 0.259 | 0.0805 | 0.180661 | 187,694 | 0.073 | 61.86% |
| 1 Year | 0.281 | 0.34 | 0.0805 | 0.1689014 | 189,693 | -0.09 | -32.03% |
| 3 Years | 0.24 | 0.36 | 0.0805 | 0.1863116 | 194,505 | -0.049 | -20.42% |
| 5 Years | 0.24 | 0.36 | 0.0805 | 0.1863116 | 194,505 | -0.049 | -20.42% |
Oncotelic Therapeutics (QB) Description
| Oncotelic Therapeutics, Inc. (OTLC) are developing three lines of therapeutics. 1) Oncology/Virology - we are developing OT-101 (TGF-beta antisense/ Artemisinin) and VDA agents (Oxi4503/CA4P) against viral infections and various tumors including three rare pediatric tumors (DIPG, Melanoma, and AML). The program is being funded by our partner GMP through a JV that we are intend to take IPO. 2) AL-101 (intranasal-apomorphine) for the treatment of Parkinson Disease, Erectile Dysfunction not responding to PDE5 inhibitor, and Female Sexual Dysfunction. 3) Animal health product including oncology (CA4P and Artemishas). |